Bruker Corporation
BRKRNASDAQHealthcareMedical Devices
As of Oct 23, 2026 close
- Market cap
- $8.77B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- 0.35%
- 52-week range
- $32.37$66.98
- Volume (live)
- -
- Avg. volume (3M)
- 2.34M
Bruker (BRKR) Stock Price & Financial Analysis
Bruker Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $55.32 - $57.78 |
|---|---|
| 52-Week High | $66.98 |
| 52-Week Low | $32.37 |
| Open | $56.93 |
| Volume (last close) | 1.22M |
| Average Volume (3M) | 2.34M |
| Revenue (TTM) | 3.50B |
|---|---|
| Net Income (TTM) | -74.00M |
| Free Cash Flow (TTM) | 93.90M |
| EPS (TTM) | −$0.49 |
| Profit Margin | -2.11% |
| Operating Margin | 5.12% |
| Return on Equity (ROE) | -3.11% |
| Debt to Equity | 0.77 |
| Annual Dividend | $0.20 |
|---|---|
| Dividend Yield | 0.35% |
| Last Dividend Ex-Date | Sep 21, 2026 |
| Market Cap | 8.77B |
|---|---|
| Shares Outstanding | 152.30M |
| Price to Sales (P/S) | 2.51 |
| Price to Book (P/B) | 3.68 |
| EV/EBITDA | 19.28 |
| 50-Day MA | $58.72 |
|---|---|
| 200-Day MA | $49.93 |
| 1-Year Change | +44.32% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Bruker at a Glance
As of the Oct 23, 2026 close, Bruker (BRKR) has a market capitalization of $8.77B. The stock trades at 2.5× sales. Over the trailing twelve months it lost $74.00M on revenue of $3.50B and generated $93.90M of free cash flow. Revenue grew 1.6% year over year.
As of its latest reported balance sheet, it holds $184.90M in cash and securities against $1.82B of debt, a net debt position of $1.64B.
Bruker pays a quarterly dividend totaling $0.20 per share a year, a 0.35% yield at the Oct 23, 2026 close.
The share price is up 44.3% over the past year. At $57.59 (the Oct 23, 2026 close) it sits within its 52-week range of $32.37 to $66.98, above its 200-day moving average of $49.93.
Based on 12 professional analyst ratings from the past 90 days, the consensus is Hold with an average price target of $61.20, 6.3% above the Oct 23, 2026 close.
Frequently Asked Questions About Bruker
What is the current stock price for BRKR?
As of the Oct 23, 2026 close, BRKR stock trades at $57.59. The 52-week range is $32.37–$66.98, with a day range of $55.32–$57.78.
What is the P/E ratio for BRKR?
The P/E ratio (Price-to-Earnings) for BRKR is shown in the Key Statistics section. This valuation metric helps compare Bruker Corporation to industry peers.
Does BRKR pay dividends?
Yes, Bruker pays a 0.35% annual dividend yield as of the Oct 23, 2026 close ($0.20 per share a year). The most recent ex-dividend date was September 21, 2026.
What do analysts recommend for BRKR?
Based on ratings from 12 professional analysts over the last 90 days, the consensus for BRKR is Hold. The average 12-month price target is $61.20, a 6.3% upside from the Oct 23, 2026 close of $57.59.
What is the market cap of BRKR?
As of the Oct 23, 2026 close, Bruker's market capitalization is $8.77B, classifying it as a mid-cap company. Bruker operates in the Healthcare sector within the Medical Devices industry.